Sign up
Quantellect · Analysts · Analyst Profile

Yaron Werber

TD Cowen · Equity Research Analyst

Analyst rating accuracy & track record

Yaron Werber does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.

Ratings & price targets

StockRatingPrice targetRated12-mo vs sectorPT hit
RAREUltragenyx
Buy$75.00Nov 2025−77.5%Miss
EXELExelixis Inc
Buy$51.00Nov 2025+40.6%Hit
ARGXargenx NV ADR
Buy$1146.00Oct 2025−23.0%Miss
IONSIonis Pharmaceuticals Inc
Buy$99.00Oct 2025−70.7%Miss
SEPNSepterna, Inc. Common Stock
Buy—Nov 2024−5.9%—
UPBUpstream Bio, Inc.
Buy—Nov 2024−9.9%—
ONCBeiGene, Ltd.
Buy$254.00May 2024+50.1%Hit
ONCBeiGene, Ltd.
Buy$236.00Apr 2024+72.7%Hit
ONCBeiGene, Ltd.
Buy$429.00Feb 2021−52.4%Miss
Prev1Next
Go to

Browse the full analyst leaderboardHow analyst accuracy is scored

Every score, Win %, PT Hit % and rank is an estimate Quantellect calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.